Regeneron’s board OKs $3 billion share buyback program


Regeneron Pharmaceuticals Inc. REGN, +0.73% said late Friday its board has authorized a share buyback program of up to $3 billion, saying it’s an opportunity to continue to invest in the business given the “strength” of its balance sheet and business. Repurchases will be made from time to time at management’s discretion, the company said. Shares of Regeneron rose 1.7% in the extended session Friday after ending the regular trading day up 0.7%.

This article was originally published by Read the original article here.

Previous articleStreetwise: Steering Royal Caribbean for 33 Years
Next articleA federal grand jury has indicted former Trump adviser Steve Bannon for contempt


Please enter your comment!
Please enter your name here